Vertex Pharmaceuticals | Resultado Líquido

Preço das Ações
473.01
Mudança Diária
2.49 0.53%
Mensal
5.39%
Anual
-3.16%
Q1 Previsão
455.43




Resultado Líquido Alterar Data
AbbVie USD 1.82B 1.63B 2025-12
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Amgen USD 1.33B 1.88B 2025-12
Arrowhead Research USD -23.75M 151.49M 2025-09
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Bristol-Myers Squibb USD 2.2B 891M 2025-09
Gilead Sciences USD 3.05B 1.09B 2025-09
Incyte USD 424.17M 19.17M 2025-09
Insmed USD -370.02M 48.34M 2025-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
J&J USD 5.12B 36M 2025-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
United Therapeutics USD 338.7M 29.2M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09


Vertex Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.